• 324 Citations
  • 9 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile


  • 1996-2003 M.D., School of Medicine, National Cheng Kung University


  • 2018.08- Assistant Professor, Department of Surgery, School of Medicine, Taipei Medical University
  • 2010.02-2018.07 Instructor, Department of Surgery, School of Medicine, Taipei Medical University
  • 2008.08-2009.07 Attending Physician, Division of General Surgery, National Taiwan University Hospital Yunlin Branch
  • 2008.05-2008.07 Researcher, Division of Gastroenterological Surgery, National Cancer CenterJapan,NCC
  • 2006.07-2008.07 Chief Resident Physician, Division of General Surgery, National Taiwan University Hospital 
  • 2003.07-2008.07 Resident  Physician, Division of Surgery, National Taiwan University Hospital 

Research Interests

  • 一般外科

Fingerprint Dive into the research topics where Tung-Cheng Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


HMGA2, a New Target of Thyroid Hormone-Induced Progression in Colorectal Cancers

Lin, H., Chang, T. & Yen, Y.


Project: A - Government Institutionb - Ministry of Science and Technology


Chang, T.


Project: C - Project of Allianceu - Taipei Medical University Shuang Ho Hospital

探討antimycin A 在抗輻射性肝癌幹細胞之功效

Chang, T.


Project: C - Project of Allianceu - Taipei Medical University Shuang Ho Hospital

Research Output

  • 324 Citations
  • 9 h-Index
  • 28 Article
  • Bromelain inhibits the ability of colorectal cancer cells to proliferate via activation of ROS production and autophagy

    Chang, T. C., Wei, P. L., Makondi, P. T., Chen, W. T., Huang, C. Y. & Chang, Y. J., Jan 1 2019, In : PLoS One. 14, 1, e0210274.

    Research output: Contribution to journalArticle

  • 4 Citations (Scopus)
  • 5 Citations (Scopus)

    Enhancement by Nano-Diamino-Tetrac of Antiproliferative Action of Gefitinib on Colorectal Cancer Cells: Mediation by EGFR Sialylation and PI3K Activation

    Chang, T. C., Chin, Y. T., Nana, A. W., Wang, S. H., Liao, Y. M., Chen, Y. R., Shih, Y. J., Changou, C. A., Yang, Y. C. S., Wang, K., Whang-Peng, J., Wang, L. S., Stain, S. C., Shih, A., Lin, H. Y., Wu, C. H. & Davis, P. J., Jan 1 2018, (Accepted/In press) In : Hormones and Cancer.

    Research output: Contribution to journalArticle

  • 5 Citations (Scopus)
  • 3 Citations (Scopus)